Literature DB >> 16205929

Effects of omeprazole and gentamicin on the biochemical and histopathological alterations of the hypoxia/ reoxygenation induced intestinal injury in newborn rats.

Unal Biçakçi1, Burak Tander, Ender Aritürk, Birsen Kiliçoğlu Aydin, Oğuz Aydin, Riza Rizalar, Zafer Eren, Ferit Bernay.   

Abstract

We utilized a newborn rat model of hypoxia/reoxygenation (H/R) that resembles human necrotizing enterocolitis (NEC) to investigate the effects of omeprazole and/or gentamicin on the formation of free oxygen radicals (FOR) and bowel histopathology. For H/R, 1-day-old rats were placed into a chamber of 100% CO2 for 5 min, then they were reoxygenized for the next 5 min. The rats (n = 70) were divided into seven groups: group 1 (control), group 2 (H/R), group 3 (omeprazole), group 4 (H/R + omeprazole), group 5 (gentamicin), group 6 (H/R + gentamicin), group 7 (H/R + omeprazole + gentamicin). Gentamicin and/or omeprazole were given orally for 3 days, then all animals were killed; bowel specimens were harvested. Histopathologic injury scores (HIS) and malonyldialdehyde (MDA) and XO/(XO+XDH) rates (XO; xanthine oxidase, XDH; xanthine dehydrogenase) were measured, which reflect the FOR levels. In group 2, the HIS was significantly higher than groups 4 and 6. The mean MDA values in groups 1-7 were as follows: 54.16, 104.2, 56.85, 63.43, 62.31, 76.85, 79.13, respectively. The mean XO/(XO + XDH) levels were 0.306, 0.461, 0.286, 0.335, 0.323, 0.410, 0.375 from groups 1 -7, respectively. Group 2 rats had significantly more MDA and XO/(XO + XDH) rates versus other groups (P < 001). Histopathologic injury and biochemical results were significantly more severe in group 2 than in groups 4 and 6 (P < 001). There was no difference between groups 1 and 4 according to XO/(XO + XDH) rates. In newborn rats, H/R produces FOR, which cause serious intestinal damage. Omeprazole and/or gentamicin reduce biochemical and histopathologic bowel damage. This effect was more obvious in omeprazole treated rats. We think omeprazole may open new insights into the treatment of H/R related bowel injuries like NEC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16205929     DOI: 10.1007/s00383-005-1538-y

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  34 in total

1.  Alterations in stool flora resulting from oral kanamycin prophylaxis of necrotizing enterocolitis.

Authors:  R Boyle; J S Nelson; B S Stonestreet; G Peter; W Oh
Journal:  J Pediatr       Date:  1978-11       Impact factor: 4.406

2.  An experimental study of acute neonatal enterocolitis--the importance of breast milk.

Authors:  B Barlow; T V Santulli; W C Heird; J Pitt; W A Blanc; J N Schullinger
Journal:  J Pediatr Surg       Date:  1974-10       Impact factor: 2.545

3.  Neonatal necrotizing enterocolitis: prevention of perforation.

Authors:  M J Bell; A M Kosloske; C Benton; L W Martin
Journal:  J Pediatr Surg       Date:  1973-10       Impact factor: 2.545

4.  Hypoxia causes ischemic bowel necrosis in rats: the role of platelet-activating factor (PAF-acether).

Authors:  M S Caplan; X M Sun; W Hsueh
Journal:  Gastroenterology       Date:  1990-10       Impact factor: 22.682

5.  The relationship between the adenine nucleotide metabolism and the conversion of the xanthine oxidase enzyme system in ischemia-reperfusion of the rat small intestine.

Authors:  Y Hirata; T Taguchi; M Nakao; T Yamada; R Hirose; S Suita
Journal:  J Pediatr Surg       Date:  1996-09       Impact factor: 2.545

6.  A prospective controlled trial of oral kanamycin in the prevention of neonatal necrotizing enterocolitis.

Authors:  E A Egan; G Mantilla; R M Nelson; D V Eitzman
Journal:  J Pediatr       Date:  1976-09       Impact factor: 4.406

7.  Necrotizing enterocolitis: research agenda for a disease of unknown etiology and pathogenesis.

Authors:  R M Kliegman; W A Walker; R H Yolken
Journal:  Pediatr Res       Date:  1993-12       Impact factor: 3.756

8.  Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine: a reevaluation.

Authors:  D A Parks; T K Williams; J S Beckman
Journal:  Am J Physiol       Date:  1988-05

9.  Does sucralfate prevent apoptosis occurring in the ischemia/reperfusion-induced intestinal injury?

Authors:  A Sencan; O Yilmaz; E Ozer; C Günşar; K Genç; C Ulukuş; C Taneli; E Mir
Journal:  Eur J Pediatr Surg       Date:  2003-08       Impact factor: 2.191

10.  A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical.

Authors:  Kaushik Biswas; Uday Bandyopadhyay; Ishita Chattopadhyay; Archana Varadaraj; Esahak Ali; Ranajit K Banerjee
Journal:  J Biol Chem       Date:  2003-01-15       Impact factor: 5.157

View more
  9 in total

1.  Suppression of proinflammatory cytokine production in macrophages by lansoprazole.

Authors:  Akinari Hinoki; Kazunori Yoshimura; Keiko Fujita; Masumi Akita; Rie Ikeda; Masabumi Nagashima; Masahiko Nomura; Akira Satomi
Journal:  Pediatr Surg Int       Date:  2006-11       Impact factor: 1.827

2.  Biochemical and histopathologic effects of omeprazole and vitamin E in rats with corrosive esophageal burns.

Authors:  Banu Topaloglu; Unal Bicakci; Burak Tander; Ender Ariturk; Birsen Kilicoglu-Aydin; Oguz Aydin; Riza Rizalar; Suat H Ayyildiz; Ferit Bernay
Journal:  Pediatr Surg Int       Date:  2008-03-20       Impact factor: 1.827

3.  Protective effects of vitamin E and omeprazole on the hypoxia/reoxygenation induced intestinal injury in newborn rats.

Authors:  Faysal O Cadir; Unal Bicakci; Burak Tander; Birsen Kilicoglu-Aydin; Riza Rizalar; Ender Ariturk; Oguz Aydin; Ferit Bernay
Journal:  Pediatr Surg Int       Date:  2008-04-22       Impact factor: 1.827

4.  Antibiotics increase gut metabolism and antioxidant proteins and decrease acute phase response and necrotizing enterocolitis in preterm neonates.

Authors:  Pingping Jiang; Michael Ladegaard Jensen; Malene Skovsted Cilieborg; Thomas Thymann; Jennifer Man-Fan Wan; Wai-Hung Sit; George L Tipoe; Per Torp Sangild
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

5.  Is it possible to use Proton Pump Inhibitors in COVID-19 treatment and prophylaxis?

Authors:  Şeyma Taştemur; Hilmi Ataseven
Journal:  Med Hypotheses       Date:  2020-06-20       Impact factor: 1.538

6.  Omeprazole Increases Survival Through the Inhibition of Inflammatory Mediaters in Two Rat Sepsis Models.

Authors:  Masaya Kotsuka; Yuki Hashimoto; Richi Nakatake; Tetsuya Okuyama; Masahiko Hatta; Terufumi Yoshida; Tadayoshi Okumura; Mikio Nishizawa; Masaki Kaibori; Mitsugu Sekimoto
Journal:  Shock       Date:  2022-03-01       Impact factor: 3.454

Review 7.  Assessment of drugs administered in the Middle East as part of the COVID-19 management protocols.

Authors:  Engy Elekhnawy; Walaa A Negm; Suzy A El-Sherbeni; Ahmed Zayed
Journal:  Inflammopharmacology       Date:  2022-08-26       Impact factor: 5.093

8.  Antihyperglycemic effect of Ginkgo biloba extract in streptozotocin-induced diabetes in rats.

Authors:  Daye Cheng; Bin Liang; Yunhui Li
Journal:  Biomed Res Int       Date:  2012-12-20       Impact factor: 3.411

9.  Effects of Platycodin D on Reflux Esophagitis due to Modulation of Antioxidant Defense Systems.

Authors:  Su-Yeon Cho; Chang-Hyun Song; Ji-Eun Lee; Seong Hun Choi; Sae-Kwang Ku; Soo-Jin Park
Journal:  Evid Based Complement Alternat Med       Date:  2018-03-26       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.